OTC Medicines Corner

Back to articles

One-dose-fits-all approach to aspirin therapy for primary prevention is not ideal

KEY POINT

The benefits of aspirin therapy appear to be dose dependent, with patients of higher body weight (≥70 kg) requiring higher doses to prevent cardiovascular (CV) events, and similar results observed for the long-term reduction in the risk of colorectal cancer, according to results of a meta-analysis published in the Lancet.